Purchase of laboratory supplies and consumable

The Food and Drug Administration's Division of Applied Regulatory Science is seeking laboratory supplies and consumables to support complex in vitro research models utilizing human induced pluripotent stem cells (hiPSCs). The procurement includes over 20 specialized items such as 48-well plates, fluorescent reagents, cell culture media, antibodies, and various research chemicals required for maintaining and characterizing advanced cell-based models that replicate physiologically relevant microenvironments. All materials must be new and unused to support projects evaluating drug safety and efficacy across multiple research areas. The government will evaluate submissions using a Lowest Price Technically Acceptable (LPTA) method, with technical and price factors weighted approximately equally, requiring vendors to submit separate technical volumes (limited to 10 pages) and price volumes. Questions must be submitted by Monday, September 8, 2025, at 12:00 PM Eastern Time, with quotes due through the SAM.gov posting on the same date.

This procurement operates under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a small business size standard of 1,000 employees, and no set-aside designation has been applied, making it an unrestricted solicitation. The contract requires delivery within 14 calendar days of award, with coordination through Project Officer Bhavya Bhardwaj for performance at the FDA facility in Silver Spring, Maryland. The RFQ number 75F40125Q00332 encompasses more than 20 specific line items with precise quantities to support the Division's ongoing regulatory science research program. No incumbent contractors or budget ranges were specified in the solicitation documentation, though the specialized nature of the hiPSC research materials suggests this procurement targets suppliers with expertise in advanced cell culture technologies.